ODDB.org: Open Drug Database

Sandoz Pharmaceuticals AG - Atriance, Infusionslösung

Swissmedic Registration	57899	Sequence	02
Product name	Atriance	Description	Infusionslösung
ATC-Classification	L01BB07	ATC-Description	Nelarabine
Introduction of Sequence	08.08.2007

Composition

nelarabinum 250 mg, natrii chloridum, acidum hydrochloridum aut natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 50 ml corresp. natrium 89.075 mg.

Packungsbestandteile

Galenic Form

Infusion solution

Excipiens

Active Agent	Dose
Nelarabinum	250mg / 50ml

BAG: Active Agent	Dose
Nelarabinum	250 mg

Inactive agents
Acidum Hydrochloridum aut Natrii Hydroxidum
Sodium Chloride

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
002		294.44	336.65	A	SL	Yes

2025	©ywesee GmbH